Christopher M. Koepke is a member of the Health Care & FDA Practice in Greenberg Traurig's Houston office.
Christopher has diverse and deep experience at the intersection of legal, scientific, and policy issues. Prior to joining the firm, Christopher served as regulatory counsel in the U.S. Food and Drug Administration (FDA) Office of Regulatory Policy, where he focused on policy development across numerous aspects of the FDA’s regulation of drugs and biologics. He also participated in responding to citizen petitions touching a broad array of topics. In addition, Christopher served within the Therapeutic Biologics and Biosimilars Staff (now OTBB), where he focused on policy development and licensure questions related to biologics and biosimilars.
Before joining FDA, Christopher worked in the Food, Drug, and Medical Device Regulatory Group in the D.C. office of another international law firm. He was also a judicial clerk at two federal appellate courts, as well as patent litigation associate.
